110 related articles for article (PubMed ID: 27910777)
1. Gastric Adenocarcinoma Biomarker Expression Profiles and their Prognostic Value.
Senol S; Aydin A; Kosemetin D; Ece D; Akalin I; Abuoglu H; Duran EA; Aydin D; Erkol B
J Environ Pathol Toxicol Oncol; 2016; 35(3):207-222. PubMed ID: 27910777
[TBL] [Abstract][Full Text] [Related]
2. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of Tensin4 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
[TBL] [Abstract][Full Text] [Related]
5. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer.
Zhu YP; Sheng LL; Wu J; Yang M; Cheng XF; Wu NN; Ye XB; Cai J; Wang L; Shen Q; Wu JQ
Hum Pathol; 2018 Aug; 78():28-35. PubMed ID: 29689245
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
8. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
9. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
10. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
[TBL] [Abstract][Full Text] [Related]
13. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
14. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
17. Midkine and syndecan‑1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma.
Hu XF; Yao J; Gao SG; Yang YT; Peng XQ; Feng XS
Mol Med Rep; 2014 Sep; 10(3):1409-15. PubMed ID: 25017879
[TBL] [Abstract][Full Text] [Related]
18. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
Liu H; Gao Y; Song D; Liu T; Feng Y
Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma.
Wang Z; Wang K; Dang Y; Ouyang X; Zhang F; Wang W; Wang L; Huang Q
World J Surg Oncol; 2018 Mar; 16(1):40. PubMed ID: 29499718
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Profile of Tumor Pathways and Prognostic Significance in Colon Adenocarcinomas.
Senol S; Ceyran AB; Kösemetin D; Gobanoglu B; Aydin D; Duran EA; Leblebici M
J Environ Pathol Toxicol Oncol; 2017; 36(1):29-41. PubMed ID: 28605329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]